About Indian Immunologicals Limited
Data last updated: 05 January 2026
Indian Immunologicals Limited is a public limited company based in Hyderabad, Telangana, India, a subsidiary of National Dairy Development Board. It specialises in animal pharmaceuticals and healthcare, a part of the broader pharmaceuticals sector. Incorporated on 08 October 1999, the company has been in operation for over 27 years.
Registered with ROC Hyderabad under CIN U72200TG1999PLC032666.
Capital: an authorised share capital of ₹400 Cr and a paid-up capital of ₹54 Cr. It is led by directors including Meeneshkumar Champaklal Shah and Rajeev Sivarama.
Last AGM: 12 September 2025. Financial statements filed for year ended 31 March 2025. Office: Indian Immunologicals Limited Road No. 44 Jubilee Hills, Hyderabad, Telangana, India – 500033.
As per the financials filed for FY 2025, the company reported a revenue of ₹1,512.93 Cr, a growth of 8% compared to the previous year.
It operates as a subsidiary of National Dairy Development Board.
The company is associated with 1 brand - Indian Immunologicals. As per MCA filings, the company has open charges of ₹335.16 Cr and satisfied charges of ₹887.42 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website indimmune.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressIndian Immunologicals Limited Road No. 44 Jubilee Hills, Hyderabad, Telangana, India – 500033
-
IndustryPharma, Animal Pharmaceuticals & Healthcare
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Indian Immunologicals Limited
Indian Immunologicals Limited has one previous CIN (Corporate Identification Number): U72200AP1999PLC032666. The current CIN is U72200TG1999PLC032666, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U72200TG1999PLC032666 | Current |
| U72200AP1999PLC032666 | Previous |
Associated Brands with Indian Immunologicals Limited
Indian Immunologicals Limited operates one associated brand: Indian Immunologicals. These brands represent Indian Immunologicals Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Vaccines for animal and human health are manufactured. | indimmune.com |
Competitors & Alternatives of Indian Immunologicals Limited
Brands and companies operating in the same space as Indian Immunologicals Limited include Vaxcyte, Serum Institute of India, Biological E and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Vaxcyte
|
Vaccines for infectious diseases are developed using cell-free protein synthesis. | Foster City, United States, United States | 2013 |
Serum Institute of India
|
Vaccines and immuno-biological drugs for infectious diseases are manufactured. | Pune, India, India | 1966 |
Biological E
|
Vaccines and therapeutics for multiple diseases are developed and marketed. | Hyderabad, India, India | 1953 |
RedHill Biopharma
|
Developer of therapeutics for the treatment of gastrointestinal and infectious diseases | Ramat Gan, Israel, Israel | 2009 |
Valneva
|
Prophylactic vaccines for infectious diseases are developed and advanced. | Lyon, France, France | 1999 |
Freeline
|
Gene therapy platform is developed for chronic disease treatments. | Stevenage, United Kingdom, United Kingdom | 2015 |
Vir Biotechnology
|
Developer of therapeutics for the treatment of infectious diseases | San Francisco, United States, United States | 2017 |
Cidara Therapeutics
|
Novel anti-infectives for bacterial and fungal infections are developed. | San Diego, United States, United States | 2013 |
StrideBio
|
AAV-based gene therapies for rare diseases are developed. | Durham, United States, United States | 2015 |
Altimmune
|
Vaccines for infectious diseases and solid tumors are developed. | Gaithersburg, United States, United States | 1997 |
Business Activity of Indian Immunologicals Limited
Indian Immunologicals Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Indian Immunologicals Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Indian Immunologicals Limited
Indian Immunologicals Limited is audited by Deloitte Haskins & Sells LLP for the financial year 2022. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Deloitte Haskins & Sells LLP | Locked | Locked | Locked |
Complete auditor history for Indian Immunologicals Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Indian Immunologicals Limited
Indian Immunologicals Limited is currently managed by 7 directors, with 27 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Meeneshkumar Champaklal Shah
Also directs:
North East Dairy And Foods Limited, Nddb Mrida Limited, Nddb Dairy Services and 4 more
|
Director | 15 Jul 2021 | 5 Years 1 Months | Current |
|
Rajeev Sivarama
Also directs:
North East Dairy And Foods Limited, Nddb Mrida Limited, Mother Dairy Fruit And Vegetable Private Limited and 1 more
|
Director | 06 Aug 2021 | 5 Years 0 Months | Current |
|
Anand Kumar Kanakasapapathy
Also directs:
Veterinary Vaccine India Manufacturers Association
|
Managing Director | 01 Nov 2013 | 12 Years 9 Months | Current |
|
Usha Ramachandra
Also directs:
Integrum Energy Infrastructure Limited
|
Director | 18 Mar 2025 | 1 Years 5 Months | Current |
| Devanand Chakkingal Pathayapura | Director | 12 Nov 2021 | 4 Years 9 Months | Current |
| Venkateswara Rao Thallapaka | Director | 18 Mar 2025 | 1 Years 5 Months | Current |
Financials of Indian Immunologicals Limited FY 2025 filings available
Indian Immunologicals Limited reported revenue of ₹1,512.93 Cr (up 8.00% YoY) for FY 2025.
Ten-year financial statements for Indian Immunologicals Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Indian Immunologicals Limited
Shareholding and ownership data for Indian Immunologicals Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Indian Immunologicals Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 May 2016 | Others | ₹5 Cr | Open |
| 18 Mar 2016 | Others | ₹85.16 Cr | Open |
| 12 Dec 2013 | Others | ₹40 Cr | Open |
| 14 Dec 2011 | Others | ₹85 Cr | Open |
| 02 Sep 2010 | Hdfc Bank Limited | ₹120 Cr | Open |
Total charge records: 23 View all charges
Employees and EPFO Compliance at Indian Immunologicals Limited
View historical data on people associated with Indian Immunologicals Limited, including employment history and EPFO contributions.
Employee and EPFO history for Indian Immunologicals Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Indian Immunologicals Limited
GST registrations and filing compliance for Indian Immunologicals Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Indian Immunologicals Limited
Credit ratings, litigation, and regulatory alerts for Indian Immunologicals Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Indian Immunologicals Limited
MSME payment history for Indian Immunologicals Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Indian Immunologicals Limited
Corporate group structure for Indian Immunologicals Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Indian Immunologicals Limited
MCA filings and documents for Indian Immunologicals Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Indian Immunologicals Limited
Recent News on Indian Immunologicals Limited
Frequently Asked Questions about Indian Immunologicals Limited
Indian Immunologicals Limited is an active public limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 08 October 1999 (27+ years old) and is registered under CIN U72200TG1999PLC032666.
Indian Immunologicals Limited reported revenue of ₹1,512.93 Cr for FY 2025 (up 8.00% YoY).
The current directors of Indian Immunologicals Limited are:
- Meeneshkumar Champaklal Shah - Director
- Rajeev Sivarama - Director
- Anand Kumar Kanakasapapathy - Managing Director
- Usha Ramachandra - Director
- Devanand Chakkingal Pathayapura - Director
- Venkateswara Rao Thallapaka - Director
- Sanjay Madhav Mehendale - Director
The primary industry of Indian Immunologicals Limited is pharma. The company specifically operates in animal pharmaceuticals and healthcare. The company is currently active in this sector.
Indian Immunologicals Limited can be reached at the registered office: Indian Immunologicals Limited Road No. 44 Jubilee Hills, Hyderabad, Telangana, India – 500033, or through the website indimmune.com.
The authorised capital is ₹400 Cr, and the paid-up capital is ₹54 Cr.